ACAD EBITDA Margin
Acadia Pharmaceuticals Inc · EBITDA Margin
ACAD EBITDA Margin
Latest reported10.51%period ending
ACAD Quarterly EBITDA Margin (-123.33% → 10.51%)
Quarterly ebitda margin
High-resolution chart · PNG
ACAD ebitda margin history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | EBITDA Margin |
|---|---|
| 10.5066% | |
| 2.6016% | |
| 10.2972% | |
| 17.0637% | |
| 16.3082% | |
| 12.5779% | |
| 4.7003% | |
| 16.5239% | |
| 16.4294% | |
| 12.8892% | |
| 17.8929% | |
| -23.8168% | |
| 4.9076% | |
| -37.5758% | |
| -29.6% | |
| -19.8211% | |
| -24.5632% | |
| -97.0442% | |
| -32.4034% | |
| -10.4884% | |
| -36.8587% | |
| -61.825% | |
| -54.8101% | |
| -70.6536% | |
| -39.315% | |
| -98.6488% | |
| -56.7134% | |
| -47.3326% | |
| -67.7796% | |
| -137.9453% | |
| -111.6197% | |
| -103.799% | |
| -111.0492% | |
| -110.6204% | |
| -156.5608% | |
| -182.5482% | |
| -221.0336% | |
| -576.2266% | |
| -648.7293% | |
| -1,362.7373% | |
| -73,683.5052% | |
| -1,253,100% | |
| -267,276.4706% | |
| -99,694.8718% | |
| -3,921,700% | |
| -1,010,750% | |
| -60,623.4043% | |
| -166,226.6667% | |
| -77,432.1429% | |
| -59,716.6667% | |
| -32,770.2703% | |
| -4,497.9167% | |
| -2,027.7162% | |
| -1,475.2998% | |
| -1,788.9474% | |
| -68.3726% | |
| -901.5025% | |
| -1,378% | |
| -898.6395% | |
| -866.9521% | |
| -1,423.4783% | |
| -1,303.908% | |
| 82.824% | |
| -179.9652% | |
| -181.0187% | |
| -249.5077% | |
| -467.0435% | |
| -351.3347% | |
| -692.1978% | |
| -3,995.4545% | |
| -4,372.6154% | |
| -5,428.7234% | |
| -10,467.7966% | |
| -2,267.7419% | |
| -1,134.6178% | |
| -914.3076% | |
| -613.2847% | |
| -665.7143% | |
| -764.2414% | |
| -634.071% | |
| -673.5247% | |
| -390.6583% | |
| -429.5415% | |
| -342.8066% | |
| -246.5999% | |
| -236.2808% | |
| -655.1689% | |
| -380.5224% | |
| -549.0696% | |
| -659.9632% | |
| -1,044.8769% | |
| 100% | |
| -89.5235% | |
| -123.3294% |